期刊文献+

福沙匹坦二甲葡胺的合成工艺改进研究

Improved Synthesis of Fosapitant Dimeglumine
下载PDF
导出
摘要 报道了合成标题化合物的新工艺。以(2R,3S)-2-((1R)-1-(3,5-双(三氟甲基)苯基)乙氧基)-3-(4-氟苯基)吗啉盐酸盐为起始物料,与5-氯甲基-2,4-二氢[1,2,4]三唑-3-酮反应得到5-[[(2R,3S)-2-[(1R)-1-[3,5-二(三氟甲基)苯基]乙氧基]-3-(4-氟苯基)-4-吗啉]甲基]-1,2-二氢-3H-1,2,4-三氮唑-3-酮,即阿瑞匹坦。将得到的阿瑞匹坦在碱性条件下与焦磷酸四苄酯反应得到二-O-苄基磷酸酯。然后于高压釜中采用钯碳氢化还原后与N-甲基-D-葡糖胺成盐,最终通过精制得到合格的标题化合物,产率为61.8%。标题化合物经1HNMR、13CNMR和HR-MS确认结构,本路线切实可行、条件温和、产品质量可控,具有一定的工业应用价值。 A new process for the synthetic of Fosapitant dimeglumine was reported.(2R,3S)-2-((1R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine hydrochloride as the starting material,it was reacted with 5-chloromethyl-2,4-dihydro[1,2,4]triazol-3-one to give 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholine]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one.It was Aprepitant.Aprepitant was reacted with tetrabenzyl pyrophosphate under alkaline conditions to obtain di-O-benzyl phosphate.Phosphate was reduced by palladium hydrocarbonization in autoclaves,then reacted with N-methyl-D-glucosamine to form a salt.The final sample was refined to obtain a qualified title compound,and the yield was 61.8%.The titile compound was confirmed by 1HNMR,13CNMR and HR-MS.This route is feasible,with mild conditions,controllable product quality and certain industrial value.
作者 刘春晖 马晓莉 LIU Chun-hui;MA Xiao-li(School of Chemistry and Chemical Engineering,North Minzu University,Yinchuan 750021,China;Key Laboratory of Chemical Engineering and Technology,State Ethnic Affairs Commission,North Minzu University,Yinchuan 750021,China)
出处 《化学试剂》 CAS 北大核心 2020年第6期739-743,共5页 Chemical Reagents
基金 北方民族大学重点科研项目(2017KJ16) 宁夏自然科学基金资助项目(2019AAC03113) 宁夏高等学校科学研究项目(NGY2017165)。
关键词 福沙匹坦二甲葡胺 阿瑞匹坦 合成 工艺 优化 Fosapitant dimeglumine Aprepitant synthesis technology optimize
  • 相关文献

参考文献7

二级参考文献78

  • 1聂映,毕小玲,尤启冬.阿瑞吡坦[J].中国新药杂志,2006,15(3):238-239. 被引量:16
  • 2纳涛.葛兰素史克公司开发出新型抗癌药relacatib及支持疗法止吐药casopitant[J].药学进展,2006,30(3):141-141. 被引量:5
  • 3张晓静,张频.肿瘤化疗所致恶心呕吐的发生机制和药物治疗的研究进展[J].癌症进展,2006,4(4):348-354. 被引量:128
  • 4温悦,王丽婷.5-HT_3受体拮抗药研究概况[J].中国药师,2006,9(10):961-962. 被引量:8
  • 5Nasser H, Pierre B. Neurokinin-1 receptor antagonists modulate brain noradrenaline and serotonin interactions[J]. EurJ Pharmacol, 2008, 600 (1-3): 64-70.
  • 6Diemunsch P, Grmalot L. Potential of substance P antagonists as antiemetics[J]. Drugs, 2000, 60(3): 533-546.
  • 7Chawla SP, Grunberg SM, Gralla RJ, et al. Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemother- apy-induced nausea and vomiting[J]. Cancer, 2003, 97(9): 2290-2300.
  • 8Antonarakis ES, Hain RDW. Nausea and vomiting associated with cancer chemotherapy: drug management in theory and practice[J]. Arch Dis Child, 2004, 89(9): 877-880.
  • 9Paul B, TrovatoJA, Thompson J, et al. Efficacy of aprepitant in pa- dents receiving high-dose chemotherapy with hematopoiedc stern cell support[J]. T Oncol Pharm Pract, 2010, 16(1): 45-51.
  • 10Frame DG. Multiple neurotransmitters and receptors and the need for combination therapeutic approaches[J]. J Support Oncol, 2010, 8(2): 5-9.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部